[Resistance formation in the cytostatic treatment of carcinomas].
D000230:Adenocarcinoma / Q000188:drug therapy; D001345:Autoradiography; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003537:Cystadenoma / Q000188:drug therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006106:Granulosa Cell Tumor / Q000188:drug therapy; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum / Q000378:metabolism / Q000627:therapeutic use*; D014316:Tritium; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D014316:Tritium
Probleme der Resistenzbildung bei der zytostatischen Behandlung von Karzinomen.